Realm Therapeutics plc (RLM) Reports Top-line Results for Phase 2 Trial of PR022 in Atopic Dermatitis; Hires Advisor for Strategic Review Including Formal Sale Process Sep 17, 2018 07:03AM
Realm Therapeutics Provides Corporate Update and Hires Advisor to Support Strategic Review including Formal Sale Process Sep 17, 2018 07:00AM